The weekly litigation news digest is live. Subscribe now

Anti-Cd20 Antibody - EP3507369

The patent EP3507369 was granted to Beijing Mabworks Biotech on Jun 12, 2024. The application was originally filed on Aug 28, 2017 under application number EP17845369A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3507369

BEIJING MABWORKS BIOTECH
Application Number
EP17845369A
Filing Date
Aug 28, 2017
Status
Granted And Under Opposition
May 10, 2024
Publication Date
Jun 12, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ARROWHOUSEMar 12, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
KAROMar 11, 2025-ADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONCN20051064335
DESCRIPTIONUS5736137
DESCRIPTIONWO2016068799
INTERNATIONAL-SEARCH-REPORTCN104768581
INTERNATIONAL-SEARCH-REPORTCN104936985
INTERNATIONAL-SEARCH-REPORTCN105143270
INTERNATIONAL-SEARCH-REPORTCN105899535
OPPOSITIONCN107384932
OPPOSITIONCN107881160
OPPOSITIONEP3666891
OPPOSITIONWO03035835
OPPOSITIONWO2005044859
OPPOSITIONWO2014160490
OPPOSITIONWO2016068799
SEARCHWO2013013013
SEARCHWO2016068799

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents